Potomac Fund Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$775K Sell
3,171
-391
-11% -$91.1K 0.03% 57
2025
Q4
$737K Sell
3,562
-520
-13% -$103K 0.03% 60
2025
Q3
$757K Sell
4,082
-228
-5% -$39.1K 0.03% 61
2025
Q2
$710K Sell
4,310
-225
-5% -$34.6K 0.04% 58
2025
Q1
$712K Buy
4,535
+216
+5% +$33.8K 0.31% 40
2024
Q4
$625K Buy
+4,319
New +$669K 0.04% 60

Other funds holding JNJ

Potomac Fund Management's JNJ Position: Q1 2026 in Review

Potomac Fund Management reduced its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, selling an estimated $91.1K and leaving 3,171 shares worth $775K. The position accounts for 0.03% of the portfolio, ranked #57.

Potomac Fund Management first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Potomac Fund Management held 3,171 shares of Johnson & Johnson worth $775K as of Q1 2026.
  • Potomac Fund Management sold 391 Johnson & Johnson shares in Q1 2026, an estimated $91.1K.
  • Johnson & Johnson made up 0.03% of Potomac Fund Management's portfolio in Q1 2026, its #57 holding.
  • Potomac Fund Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Potomac Fund Management's 13F filing for Q1 2026, filed 14 May 2026.